Document is current

Any future updates will be listed below

Comment on: ‘Comparing safety and efficacy of Bevacizumab, Ranibizumab and Ranibizumab biosimilar in Retinopathy of prematurity’

Crossref DOI link: https://doi.org/10.1038/s41433-025-03875-2

Published Online: 2025-06-17

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark